December 2025 International Monthly Webinar
Date: Thursday, December 18
Time: 2 p.m. EST
Each month, we bring together voices from across the oncology care spectrum to share what’s new, what’s working, and what’s next. This month, we’re highlighting emerging therapies, supportive care strategies, and tools designed to strengthen patient management across multiple cancer types.
This Month’s Lineup:
Opening remarks from Michelle Phillips, PharmD, BCOP (University of Rochester Medical Center, UR Specialty Pharmacy)
PQI: Datopotamab Deruxtecan (DATROWAY®): Prophylaxis and Management of Adverse Events – Abigail Shockley, PharmD (MD Anderson Cancer Center), reviews key considerations for supporting patients receiving datopotamab deruxtecan, focusing on how proactive AE recognition and prevention, guided by NCODA’s PQI resource, can improve safety, consistency, and day-to-day tolerability in clinical practice.
PQIinA: Darolutamide (NUBEQA®) and What’s Ahead – This overview of darolutamide explores its role in prostate cancer care and what clinicians should anticipate as indications evolve. The session introduces how NCODA’s PQIinA framework supports safe, streamlined dispensing and patient monitoring for this emerging therapy.
OGSIVEO® (Nirogacestat) Medically Integrated Oncology Treatment Discussion Guide Overview – Tony Philip, MD, FACP, FASCO (Northwell Health Cancer), walks through the medically integrated treatment guide for nirogacestat, offering insights into patient identification, key monitoring needs, and how MIOT resources can help teams coordinate care and strengthen communication around this therapy.
Imetelstat (Rytelo™): A Treatment for Low-Risk Myelodysplastic Syndrome (LR-MDS) – Nikolas Rademaker, DNP, FNP-BC (Cancer Care Northwest), provides an overview of imetelstat for LR-MDS, covering clinical considerations for patient selection, expected treatment responses, and supportive care elements that help practices deliver safe, continuous management for this patient population.
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Additional Upcoming Webinars
Upcoming Webinar
BRAF V600E NSCLC: Updated Evidence for Encorafenib + Binimetinib
December 15, 2025 | 5:00 PM